Early Data With Olaratumab in Soft Tissue Sarcoma
3 Pogledi
• 07/18/23
0
0
Ugraditi
administrator
Pretplatnici
The panelists, Brian Van Tine, MD, PhD; Shreyaskumar Patel, MD; Robin L. Jones, MD, MRCP; Jonathan Trent, MD, PhD; and Andrew Wagner, MD; discuss phase I/II data with olaratumab and its mechanism of action.
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari